About Us

Shenzhen Weiguang Biological Products Co., Ltd. (stock code: 002880) is a national high-tech enterprise, the only blood products manufacturing enterprise in Shenzhen, and a state-controlled listed enterprise in Guangming District. Founded in 1985, the company is mainly engaged in the research and development, production and sales of blood products. Products including human albumin, intravenous human immunoglobulin, a total of 9 varieties and 21 specifications. The company has won many honors such as "Guangdong Independent Innovation Demonstration Enterprise", "Shenzhen Science and Technology Innovation Award", "Shenzhen Top 100 Quality Enterprise" and "Shenzhen Top 100 Brand".

  • 0
    production base
  • 120million cumulative
    sales of products
  • 0
    patents
  • 0
    echnical service platforms

Full production
process control

Full distribution
traceability

Full staff
pharmacovigilance

100% quality and safety

Professional Park

Life Science Park

Weiguang Life Science Park is a specialized synthetic bio-industrial park built by Shenzhen Weiguang Biological Prod ...

Park Orientation

Grasp the golden opportunity of "double zone" drive and "double zone" overlap, rely on the construction of the first ...

Park Advantages

Weiguang Life Science Park is located in the core area of science and education in Guangming Science City, with conv ...

Construction Overview

On December 25, 2021, the second phase of Weiguang Life Science Park (main body) was topped out.

Overlooking the park

The first phase、second phase of the park has been fully put into use, equipped with supporting facilities such as se ...

News

loading...

2022 Spring Recruitment is coming, Weiguang is waiting for you!

2022 Weiguang biological spring recruitment has started, ...

loading...

Weiguang Biological held the 2022 Work Conference

"Struggle makes dreams come true, contribution makes bri ...

loading...

Weiguang Life Science Park was awarded "Guangming District Biomedical Specialty Industry Creation Park"

On the afternoon of December 1st, the 2021 Guangming Inv ...